Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENDOXAN INJ vs ERDAFITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENDOXAN INJ vs ERDAFITINIB: Safety Overview

Metric ENDOXAN INJ ERDAFITINIB
Total FAERS Reports 107 1,106
Deaths Reported 67 315
Death Rate 62.6% 28.5%
Hospitalizations 0 226
Average Patient Age 49.0 yrs 66.6 yrs
% Female Patients N/A 37.9%
FDA Approval Date N/A Apr 12, 2019
Manufacturer N/A Janssen Products LP
Route N/A ORAL
Marketing Status N/A Prescription